CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury

TGF-β-Induced CD8+CD103+ Regulatory T Cells Show Potent Therapeutic Effect on Chronic Graft-versus-Host Disease Lupus by Suppressing B Cells

(2018) Haowen Zhong et al.   Frontiers in Immunology

CD8+iTregs attenuate glomerular endothelial cell injury in lupus-prone mice through blocking the activation of p38 MAPK and NF-κB

(2018) Ya Liu et al.   MOLECULAR IMMUNOLOGY

Cutting Edge: Foxp3+CD4+CD25+ Regulatory T Cells Induced by IL-2 and TGF-  Are Resistant to Th17 Conversion by IL-6

(2014) S. G. Zheng et al.   JOURNAL OF IMMUNOLOGY

Phenotypic and functional characteristic of a newly identified CD8+Foxp3−CD103+ regulatory T cells

(2013) Ya Liu et al.   Journal of Molecular Cell Biology

Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis

(2012) Sandeep Singh et al.   ARTHRITIS RESEARCH & THERAPY

CD4+CD25+Foxp3+Regulatory T Cells Protect Endothelial Function Impaired by Oxidized Low Density Lipoprotein via the KLF-2 Transcription Factor

(2011) Ming Li et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Foxp3+-Inducible Regulatory T Cells Suppress Endothelial Activation and Leukocyte Recruitment

(2011) E. Maganto-Garcia et al.   JOURNAL OF IMMUNOLOGY

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

(2011) Andrea Facciabene et al.   NATURE

Systemic Lupus Erythematosus

(2011) George C. Tsokos   NEW ENGLAND JOURNAL OF MEDICINE

Induced Foxp3+ regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?

(2011) Q. Lan et al.   Journal of Molecular Cell Biology

CD4 + CD25 + Foxp3 + Regulatory T Cells Protect the Proinflammatory Activation of Human Umbilical Vein Endothelial Cells

(2010) Shaolin He et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus

(2010) Ana Henriques et al.   CELLULAR IMMUNOLOGY

Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

(2010) P. E. SPRONK et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus

(2010) Mojtaba Habibagahi et al.   RHEUMATOLOGY INTERNATIONAL

Long-term mortality and renal outcome in a cohort of 100 patients with Lupus Nephritis

(2010) Mikkel Faurschou et al.   ARTHRITIS CARE & RESEARCH

Th17 and natural Treg cell population dynamics in systemic lupus erythematosus

(2009) Ji Yang et al.   ARTHRITIS AND RHEUMATISM

Regulatory T Cells and Immune Tolerance

(2008) Shimon Sakaguchi et al.   CELL

Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/fas lpr mice

(2008) M. Ursula Norman et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Chemokine blockade for lupus model mice

(2007) Hitoshi Hasegawa   Frontiers in Bioscience-Landmark